Market Value3,088,173,822
Total Holdings69
File Date2025-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ALLK / Allakos Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
CYTK / Cytokinetics, Incorporated
INSM / Insmed Incorporated
MAZE / Maze Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
IONS / Ionis Pharmaceuticals, Inc.
PTGX / Protagonist Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
IVVD / Invivyd, Inc.
OKUR / OnKure Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
SRPT / Sarepta Therapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
CNTX / Context Therapeutics Inc.
IKNA / Ikena Oncology, Inc.
RGLS / Regulus Therapeutics Inc.
XENE / Xenon Pharmaceuticals Inc.
CLYM / Climb Bio, Inc.
GHRS / GH Research PLC
ANIP / ANI Pharmaceuticals, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
ZURA / Zura Bio Limited
TARS / Tarsus Pharmaceuticals, Inc.
UPB / Upstream Bio, Inc.
CYBN / Cybin Inc.
XNCR / Xencor, Inc.
MBX / MBX Biosciences, Inc.
ORKA / Oruka Therapeutics, Inc.
SEPN / Septerna, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
IMVT / Immunovant, Inc.
AKRO / Akero Therapeutics, Inc.
GH / Guardant Health, Inc.
VRDN / Viridian Therapeutics, Inc.
BCAX / Bicara Therapeutics Inc.
ALGS / Aligos Therapeutics, Inc.
KRRO / Korro Bio, Inc.
ENGN / enGene Holdings Inc.
SYRE / Spyre Therapeutics, Inc.
AMGN / Amgen Inc.
OCUL / Ocular Therapeutix, Inc.
RAPT / RAPT Therapeutics, Inc.
NMRA / Neumora Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
NMRA / Neumora Therapeutics, Inc. Call
HRMY / Harmony Biosciences Holdings, Inc.
SWTX / SpringWorks Therapeutics, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
GMAB / Genmab A/S - Depositary Receipt (Common Stock)
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
SAVA / Cassava Sciences, Inc. Put
ETNB / 89bio, Inc.
DYN / Dyne Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
CLDX / Celldex Therapeutics, Inc.
AVTX / Avalo Therapeutics, Inc.
RAPP / Rapport Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
OLMA / Olema Pharmaceuticals, Inc.
NKTR / Nektar Therapeutics
MNMD / Mind Medicine (MindMed) Inc.
DVAX / Dynavax Technologies Corporation
BEAM / Beam Therapeutics Inc.
NVAX / Novavax, Inc.
MTSR / Metsera, Inc.
DNTH / Dianthus Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
BBIO / BridgeBio Pharma, Inc.
PLRX / Pliant Therapeutics, Inc.
TECX / Tectonic Therapeutic, Inc.
SAGE / Sage Therapeutics, Inc.
NGNE / Neurogene Inc.
INO / Inovio Pharmaceuticals, Inc.
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
GERN / Geron Corporation